The Research and Development Team at Lycera focuses on advancing innovative small molecule therapies targeting autoimmune diseases and cancer. Comprising experts in biology, chemistry, and preclinical development, the team collaborates to discover, design, and optimize drug candidates, rigorously evaluating their efficacy and safety in preclinical models to drive promising therapies toward clinical application.